Topiramate effect in catalonia: A case series

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 18, Issue 2, 2006, Pages 234-238

  McDaniel, William W ^a   Spiegel, David R ^a   Sahota, Anupinder K ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; LORAZEPAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; ZIPRASIDONE; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; NEUROLEPTIC AGENT;

ADULT; AGED; AGITATION; ARTICLE; CASE REPORT; CATALEPSY; CATATONIA; CLINICAL FEATURE; DELIRIUM; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; REMISSION; SEDATION; SIDE EFFECT; SYMPTOM; URINARY TRACT INFECTION; BIPOLAR DISORDER; CATAPLEXY; CATATONIC SCHIZOPHRENIA; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE;

ADULT; AGED; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CATAPLEXY; CATATONIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; RECURRENCE; SCHIZOPHRENIA, CATATONIC;

EID: 85047690725     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2006.18.2.234     Document Type: Article

References (24)

1. Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:233-1241
2. Taylor MA: Clinical examination. In Catatonia: from Psychopathology to Neurobiology. Caroff S (Ed.), Mann S, Francis A, Fricchione G: American Psychiatric Press, 2004. Washington, DC, London England
3. Fink M, Taylor MA: Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge University Press, Cambridge, UK 2003
4. Losonczy MF, Song IS, Mohs RC, et al: Correlates of lateral ventricular size in chronic schizophrenia, I behavioral and treatment response measures. Am J Psychiatry 1986; 143:976
5. Taylor MA, Abrams R: Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977; 34:1223-1225
6. Abrams R, Taylor MA, Stolurow KAC: Catatonia and mania: patterns of cerebral dysfunction. Biol Psychiatry 1979; 14:111-117
7. The American Psychiatric Association: Diagnostic and Statistical Manual IV. Washington, DC, American Psychiatric Press, 1999
8. Dhossche D, Bourman NH: Catatonia in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36:870-871
9. Dhossche D: Brief report: catatonia in autistic disorders. J Autism, Dev Discord 1998; 28:329-331
10. Cohen D, Flament M, Cubos P, et al: Case series: catatonic syndrome in young people. J Am Acad Child Adolsec Psychiatry 1999; 38:1040-1046
11. Lund CE, Mortimer AM, Rogers D, et al: Motor, volitional and behavioral disorders in schizophrenia, I: assessment using the modified rogers scale. Br J Psychiatry 1991; 158:323-327
12. Northoff G, Kock A, Wenke J, et al: Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord 1999; 14:404-416
13. Peralta V, Cuesta MJ: Motor features in psychotic disorders I: factor structure and clinical correlates. Schizophr Res 2001; 47:107-116
14. Peralta V, Cuesta MJ: Motor features in psychotic disorders, II: development of diagnostic criteria for catatonia. Schizophr Res 2001; 47:117-126
15. Rosebush PL, Mazurek M: Pharmacotherapy, in Catatonia from Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fircchione GL. Washington, DC, London American Psychiatric Press, 2004
16. Kruger S, Braunig P: Intravenous valproic acid in the treatment of severe catatonia. J Neuropsychiatry Clin Neurosci 2001; 13:303-304
17. Kritzinger PR, Jordaan GP: Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol 2001; 4:251-257
18. Millson RC: Topiramate for refractory schizophrenia. Am J Psychiatry 2002; 159:675
19. Northoff G: What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002; 25:555-577
20. Sperk G, Lassmann H, Baran H, et al: Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 1983; 10:1301-1315
21. Northoff G, Eckert J Fritze J: Glutamatergic dysfunction in catatonia? successful treatment of three acute akinetic catatonic patients with the nmda antagonist amantadine. J Neurol Neurosurg Psychiatry 1997; 62:404-406
22. Northoff G: Neuroimaging and neurophysiology, in Catatonia from Psychopathology to Neurobiology. Edited by Caroff SN, Mann SC, Francis A, Fricchione GL. Washington, DC, London, American Psychiatric Press, 2004
23. Goff DC, Coyle JT: The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158:1367-1377
24. Laruelle M, Kegeles LS, Abi-Dargham A: Glutamate, dopamine and schizophrenia: from pathophysiology to treatment. Ann NY Acad Sci 2003; 1003:138-158